Eden Research (LON:EDEN) Stock Price Down 0.2% – Here’s What Happened

Eden Research plc (LON:EDEN)’s share price traded down 0.2% during trading on Friday . The company traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). 10,000 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The stock has a 50 day moving average of GBX 3.87 and a 200 day moving average of GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The company has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insider Buying and Selling

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of the stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek bought 256,000 shares of the stock in a transaction on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). 14.02% of the stock is owned by insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.